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Abstract. 
 
Dishevelled has been implicated in the regu-
lation of cell fate decisions, cell polarity, and neuronal
function. However, the mechanism of Dishevelled ac-
tion remains poorly understood. Here we examine the
cellular localization and function of the mouse Dishev-
elled protein, DVL-1. Endogenous DVL-1 colocalizes
with axonal microtubules and sediments with brain mi-
crotubules. Expression of DVL-1 protects stable micro-
tubules from depolymerization by nocodazole in both
dividing cells and differentiated neuroblastoma cells.
Deletion analyses reveal that the PDZ domain, but not
the DEP domain, of DVL-1 is required for microtubule
stabilization. The microtubule stabilizing function of
DVL-1 is mimicked by lithium-mediated inhibition of
 
glycogen synthase kinase-3
 
b 
 
(GSK-3
 
b
 
) and blocked by
expression of GSK-3
 
b
 
. These ﬁndings suggest that
DVL-1, through GSK-3
 
b
 
, can regulate microtubule dy-
namics. This new function of DVL-1 in controlling mi-
crotubule stability may have important implications for
Dishevelled proteins in regulating cell polarity.
Key words: WNT • granule cells • cerebellum • cy-
toskeleton • nocodazole 
 
Introduction
 
Dishevelled was originally characterized as a 
 
Drosophila
 
mutation that affects planar polarity and epithelial pattern-
ing in the early embryo (Perrimon and Mahowald, 1987;
Adler, 1992; Klingensmith et al., 1994). Dishevelled is a cy-
toplasmic protein implicated in the Notch and WNT sig-
naling pathways. In the Notch pathway, Dishevelled acts as
a repressor, whereas it is a positive regulator of the WNT
signaling pathway (Klingensmith et al., 1994; Noordermeer
et al., 1994; Siegfried et al., 1994; Axelrod et al., 1996). In
 
Drosophila 
 
and 
 
Xenopus
 
 embryos, overexpression of 
 
di-
shevelled
 
 confers a similar phenotype to 
 
Wnt 
 
overexpres-
sion, suggesting that Dishevelled activates WNT signaling
(Rothbacher et al., 1995; Sokol et al., 1995; Yanagawa et
al., 1995). The current model for the canonical pathway
proposes that Wg, the 
 
Drosophila
 
 homologue of WNT, ac-
tivates Dishevelled through the Frizzled receptor to con-
trol epithelial patterning in 
 
Drosophila
 
. Activation of Di-
shevelled results in the inhibition of Shaggy (Sgg), a serine/
threonine kinase, and the homologue of glycogen synthase
 
kinase-3
 
b
 
 (GSK-3
 
b
 
).
 
1
 
 Inhibition of GSK-3
 
b
 
/Sgg leads to
increased levels of 
 
b
 
-catenin/Armadillo and the activation
of transcription via T-cell factor/Pangolin factors (Cadigan
and Nusse, 1997; Arias et al., 1999). In planar cell polarity,
however, Dishevelled activates the c-Jun NH
 
2
 
-terminal
protein kinase (JNK) pathway in an Armadillo-Pangolin–
independent manner (Boutros et al., 1998). Different do-
mains of Dishevelled are required for signaling through
these different pathways. It has been proposed that Di-
shevelled function is to interpret signals coming from the
plasma membrane and to direct them to different signaling
pathways (Boutros and Mlodzik, 1999).
Dishevelled proteins possess three conserved domains: a
DIX domain, present in the WNT antagonizing protein
Axin (Zeng et al., 1997), a PDZ domain involved in pro-
tein–protein interactions (Ponting et al., 1997), and a DEP
domain found in proteins that regulate Rho GTPases
(Ponting and Bork, 1996). In the canonical WNT pathway,
the PDZ domain is required. Whereas the DEP domain is
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essential for activation of the planar polarity pathway (for
review, see Boutros and Mlodzik, 1999). Mutation in the
DEP domain of 
 
dishevelled
 
 results in the random orienta-
tion of hair cells, suggesting that Dishevelled may control
the reorganization of the cytoskeleton in planar cell polar-
ity (Axelrod et al., 1998). Epistatic analyses support the
role of RhoA in this process (Strutt et al., 1997). Thus, Di-
shevelled may regulate the actin cytoskeleton through the
JNK pathway. However, the role of Dishevelled in regu-
lating the cytoskeleton through other pathways has not
been established.
In the mouse, three 
 
Dishevelled
 
 genes, 
 
Dvl-1
 
, 
 
Dvl-2, 
 
and
 
Dvl-3
 
 have been identified (Sussman et al., 1994; Klingen-
smith et al., 1996; Yang et al., 1996). 
 
Dvl-3
 
 is expressed
throughout development, but functional studies are miss-
ing (Tsang et al., 1996). 
 
Dvl-2
 
 is ubiquitously expressed
during embryonic development and in many adult tissues
(Klingensmith et al., 1996). More recently, 
 
Dvl-2
 
 has been
shown to be highly expressed in the outer root sheath and
hair precursor cells (Millar et al., 1999). Studies using
transgenic mice show that mouse Dishevelled protein,
DVL-2, mimics WNT-3 function and therefore suggest
that DVL-2 is part of the WNT signaling pathway involved
in hair development (Millar et al., 1999). Like 
 
Dvl-2,
 
 
 
Dvl-1
 
is ubiquitously expressed at early stages of development
(Sussman et al., 1994). In the central nervous system
(CNS), 
 
Dvl-1 
 
is highly expressed in areas of high neuronal
density at embryonic and postnatal stages of development
(Sussman et al., 1994). Analysis of the 
 
Dvl-1 
 
null mouse
shows that 
 
Dvl-1 
 
is not required for early development.
However, 
 
Dvl-1 
 
null mice exhibit behavioral abnormali-
ties and neurological deficits, suggesting that DVL-1 is re-
quired for the formation and/or function of specific neu-
ronal pathways (Lijam et al., 1997).
Neurons are highly polarized cells with stereotypic den-
dritic arborizations and axons. The neuronal cytoskeleton
is essential for the formation and maintenance of this po-
larized morphology. Recent studies on cerebellar neurons
have demonstrated that WNT-7a regulates axonal mor-
phology. WNT-7a increases growth cone size and axonal
branching, while decreasing axon length (Lucas and Sali-
nas, 1997; Hall et al., 2000). These changes are mediated
through the inhibition of GSK-3
 
b
 
. The axonal remodelling
activity of WNT-7a is associated with changes in microtu-
bule (MT) organization (Hall et al., 2000), and the GSK-
3
 
b
 
–mediated phosphorylation of the microtubule-associ-
ated protein, MAP-1B (Lucas et al., 1998). GSK-3
 
b
 
 also
phosphorylates Tau, an axonal microtubule-associated
protein that, like MAP-1B, is involved in MT stability
(Hanger et al., 1992). These findings suggest that GSK-3
 
b
 
regulates the organization of neuronal MTs by changing
the phosphorylation of MAPs. However, the mechanisms
controlling GSK-3
 
b
 
 activity during MT reorganization re-
main poorly understood.
Here we examine the expression and function of DVL-1,
a regulator of GSK-3
 
b
 
, in developing neurons. In the CNS,
DVL-1 is localized to neurons of the cortex, hippocampus,
pons, and cerebellum. Three isoforms of DVL-1 are differ-
entially expressed during neuronal maturation. DVL-1
colocalizes with axonal MTs and sediments with brain
MTs. Expression of DVL-1 protects stable MTs from de-
 
polymerization by nocodazole. The PDZ domain and, to a
lesser extent, the DIX domain of DVL-1 are required for
MT stabilization. Furthermore, this process is mediated by
the inhibition of GSK-3
 
b
 
. These findings demonstrate a
novel function for DVL-1 in regulating MT organization.
 
Materials and Methods
 
Production of DVL-1 Antibodies
 
Polyclonal DVL-1 antibody was made against the carboxy-terminal 46
amino acids of DVL-1 fused to glutathione S-transferase protein (GST-
DVL-46; kindly provided by Karl Willert and Roel Nusse, Stanford Uni-
versity, Stanford, CA). Specific DVL-1 antibody was affinity purified
using CNBr-Sepharose bead coupled to GST-DVL-46. The obtained anti-
serum was run through a GST column, and then affinity purified on a
GST-DVL-46 column (Pierce Chemical Co.). This antibody, but not the
preimmune serum, recognized the DVL-1 protein in Western blots. Anti-
body specificity was confirmed by the lack of DVL-1 immunoreactivity in
cerebellar protein extracts isolated from the 
 
DVL-1 
 
null mutant mice
(Lijam et al., 1997) and by blocking with purified GST-DVL-46 peptide.
 
Neuronal Cell Cultures
 
Cerebellar granule cells were isolated from newborn mice and purified us-
ing Percoll gradients (Hatten, 1985). Neurons were plated onto laminin-
coated dishes at a density of 10
 
5
 
 cells/cm
 
2 
 
and grown in serum-free me-
dium for 2 d, as described previously (Lucas et al., 1998). Cells were fixed
either in 4% formaldehyde in PBS or in 3% paraformaldehyde, 0.2% glu-
taraldehyde, 0.2% Triton X-100, 10 mM EGTA in PBS (detergent fixa-
tion) and stored in PBS at 4
 
8
 
C.
 
Immunofluorescence Microscopy
 
Fixed cultures were incubated with primary antibodies overnight at 4
 
8
 
C.
Goat anti–rabbit IgG and goat anti–mouse IgG antibodies labeled with Al-
exa 568 and Alexa 488, respectively (Molecular Probes), and anti–rat IgG-
FITC from Vector or anti–rat IgG-AMCA (Chemicon) were used as
secondary antibodies. Images were obtained with a microscope (BX60;
Olympus) or with a laser scanning confocal microscope (DMR; Leica).
Photographic images were scanned, stored as TIFF files, and analyzed us-
ing Photoshop 4.0 (Adobe Systems Inc.). Other primary antibodies used
were against acetylated tubulin (Sigma-Aldrich), growth associated pro-
tein-43 (GAP-43; monoclonal, Boehringer; polyclonal from Dr. Graham
Wilkin, Imperial College, London, UK), and hemagglutinin (HA; Boeh-
ringer). For immunohistochemistry, brain tissues were fixed with 4%
paraformaldehyde (PFA), embedded in polyfreeze tissue embedding me-
dium (Polysciences, Inc.), and stored at 
 
2
 
70
 
8
 
C. Cryosections of 18 
 
m
 
m were
fixed again in 4% PFA and incubated with DVL-1 antibody overnight. An-
tibody was visualized with the ABC kit (Vector Laboratories) and DAB.
No staining was obtained with DVL-1 antibody previously blocked with pu-
rified GST-DVL-46 peptide.
 
Taxol Polymerization and Cycling of Microtubules
 
For taxol experiments, crude MTs were prepared from mouse cerebellum
using a method adapted from Fujii et al. (1990). Dissected cerebella were
homogenized on ice in MES buffer (100 mM MES, pH 6.5, 0.5 mM mag-
nesium acetate, 1 mM dithiothreitol, 1 mM EGTA, 100 
 
m
 
g/ml PMSF, 10
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml pepstatin, and 10 
 
m
 
g/ml leupeptin) and centri-
fuged at 4
 
8
 
C for 40 min at 180,000 
 
g
 
. The supernatant was removed and in-
cubated with 10 
 
m
 
M taxol and 1 mM GTP at 37
 
8
 
C for 30 min to polymer-
ize the MTs. The sample was then centrifuged at 100,000 
 
g
 
 for 30 min at
25
 
8
 
C to recover the crude MT pellet, which was then resuspended in gel
loading buffer.
In MT cycling experiments, crude MT protein from mouse brain was
cycled twice through successive rounds of MT assembly and disassembly.
In brief, whole mouse brain was homogenized in PEM buffer (100 mM
PIPES, pH 6.8, 2 mM EGTA, 1 mM MgCl
 
2
 
) with 1 mM ATP and 0.1 mM
GTP. After centrifugation at 100,000 
 
g
 
 for 1 h at 4
 
8
 
C, the homogenate was
added to an equal volume of PEM buffer containing 8 M glycerol, 1 mM
ATP, and 1 mM GTP. The solution was incubated at 37
 
8
 
C for 30 min and
spun again for 1 h at room temperature to collect the polymerized MT 
Krylova et al. 
 
Mouse Dishevelled Protein, DVL-1, Regulates Microtubule Stability
 
85
 
fraction (P1) and supernatant (S1). MTs were depolymerized by incubat-
ing on ice for 1 h, and then spun down at 100,000 
 
g
 
, 4
 
8
 
C, to collect the cold
stable MT fraction (CSP1). The supernatant was then incubated at 37
 
8
 
C
for 30 min to polymerize MTs again, and spun down to obtain supernatant
(S2) and MT pellet (P2). The P2 fraction was then subjected to a further
cycle of temperature-dependent depolymerization and repolymerization.
In a second set of experiments, DVL-HA, obtained from cell lysates of
DVL-HA–transfected COS cells, was added to the crude MT suspension
before two successive cycles of cold/warm exposure. Aliquots were re-
moved for Western analysis. Endogenous DVL-1 protein was detected
with DVL-1 antibody and DVL-HA with the HA antibody.
 
Western Blot Analysis
 
Mouse cerebella or whole brains were dissected and homogenized in cold
sample buffer. Boiled tissue samples or cultured cell extracts were run on
10% SDS-PAGE gels and proteins were transferred to Hybond-C super
(Amersham Pharmacia Biotech) membranes and probed with antibodies
against DVL-1, MAP-1B (kindly provided by P. Gordon-Weeks, King’s
College, London, UK), 
 
a
 
-tubulin, and extracellular signal-regulated ki-
nase (Erk), and developed using HRP-coupled anti–rabbit (Sigma-Aldrich)
or anti-mouse (Amersham Pharmacia Biotech) antibodies and electro-
chemiluminescence reagent (Pierce Chemical Co.). Protein levels were
normalized using the BSA protein assay (Pierce Chemical Co.) and Coo-
massie blue or by staining the membranes with Ponceau red.
 
Plasmids and Transfections
 
DVL-HA, DVL-1 deletion mutants, and GSK-3
 
b
 
-HA constructs were
generated by PCR using the high fidelity thermostable DNA polymerase
plaque-forming units (Stratagene or Promega) and cloned into the
pCS2
 
1
 
 expression vector. Constructs were verified by DNA sequencing.
The expression of green-fluorescent protein (GFP), DVL-HA constructs,
and GSK-3
 
b
 
-HA were driven by the cytomegalovirus promoter. DVL-1,
without the tag, was driven by the SV40 promoter. Plasmids for transfec-
tion were isolated using a maxi-prep endotoxin-free kit (QIAGEN).
COS cells were transfected using the calcium-phosphate technique and
cultured for another 48 h. Neuroblastoma 2a (NB2a) cells were trans-
fected using Lipofectamin (GIBCO-BRL), and then differentiated for
48 h in the presence of 1 mM dibutyryl-cyclic-AMP. Cells were treated
with nocodazole (10 or 5 
 
m
 
M) for 1 h and fixed in 3% formaldehyde,
0.2% glutaraldehyde, 0.2% Triton X-100, and 10 mM EGTA in PBS.
 
Results
 
DVL-1 Is Expressed during Postnatal Development
 
To examine the function of DVL-1 in neuronal develop-
ment, we generated an affinity-purified polyclonal anti-
body against a peptide encoding the 46 carboxy-terminal
amino acids of DVL-1. Using this antibody, we found that
DVL-1 is localized to several neuronal populations of the
adult mouse CNS. High levels of DVL-1 protein were
found in neurons of the cerebral cortex, hippocampus,
pons, and cerebellum (Fig. 1, A–J). In the cortex, DVL-1 is
localized to the cell body and processes of neurons (Fig. 1
A). High levels of DVL-1 were found in pyramidal neu-
rons (Fig. 1 A, insert). In the cerebellum, we examined in
more detail the distribution of DVL-1 during postnatal
cerebellar development (Fig. 1, D–J). At birth, DVL-1 was
found in the external granular cell layer (EGL) and in the
forming internal granule cell layer (IGL) of the cerebel-
lum (Fig. 1 D). At P7, the level of DVL-1 is higher in the
EGL as granule cells migrate to the IGL. DVL-1 was also
observed in the forming IGL (Fig. 1 E). By P14, DVL-1 is
highly expressed in the granule cell layer and this expres-
sion is maintained in adult life (Fig. 1, F–J). DVL-1 is also
expressed in the Purkinje cell layer, when Purkinje cells
begin to mature and develop a complex dendritic tree (Fig.
1, F–J). From P21, low levels of DVL-1 were found in the
molecular layer (Fig. 1, G–I). In 
 
Dvl-1 
 
null mutant mice,
no immunoreactivity was observed (Fig. 1 K). Preincuba-
tion of the antibody with the DVL-46 peptide completely
Figure 1. DVL-1 expression in postnatal mouse
brain. Brain sections were immunostained for
DVL-1 (A–J). The highest level of DVL-1 was
detected in neurons of the cerebral cortex, hip-
pocampus, pons, and cerebellum (A–C and I).
(A, inset) DVL-1 localization in cell bodies and
processes of pyramidal neurons. In P0 cerebel-
lum, DVL-1 is expressed in the EGL and forming
IGL (D). At P7, DVL-1 immunoreactivity in-
creases in the EGL (E). At P14, DVL-1 was
mainly localized in the granule cell layer (GCL)
and in the Purkinje cell (PC) layer (F). This pat-
tern of DVL-1 expression was maintained
throughout life (G–I). A low level of DVL-1 ex-
pression was detected in the molecular layer
(ML) from P21 (G–I). At P21, DVL-1 is mainly
localized in granule cells and Purkinje cells cell
bodies, as shown at higher magnification (J). No
immunoreactivity was detected in the cerebellum
of adult Dvl-1 null mutant mice (K). Preincuba-
tion of the antibody with DVL-46 peptide com-
pletely abolished immunostaining in adult cere-
bellum (L). AD, adult; DG, dentate gyrus. Bar,
100 mM. 
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abolishes DVL-1 staining in adult mouse cerebellum (Fig.
1 L). These results show that DVL-1 is mainly localized to
neurons throughout life.
We next examined the levels of DVL-1 in the develop-
ing cerebellum by Western analysis. The DVL-1 antibody
recognizes three main species migrating with apparent
molecular weights of 96, 88, and 83 kD. None of the three
species were detected in cerebellar samples isolated from
 
Dvl-1 
 
null
 
 
 
mice, confirming the specificity of our antibody
(Fig. 2). The three species of DVL-1 are developmentally
regulated. The 96- and 88-kD proteins are present at birth,
but their expression declines as development progresses
(Fig. 2). In contrast, the lowest molecular weight form (83
kD) increases from P0 to adulthood (Fig. 2). These
changes in the mobility of DVL-1 correlate with neuronal
maturation, a process characterized by axonal extension
and the formation of dendritic arborizations and synapses.
 
DVL-1 Colocalizes with Axonal Microtubules
 
To determine the localization of DVL-1 in neurons, we
examined DVL-1 in cerebellar granule cell cultures. Dou-
ble labeling for GAP-43, a protein that reveals neuronal
morphology, shows that DVL-1 protein has a punctate
distribution in the cell body, along the axon shaft and at
the growth cone (Fig. 3, A–F). At the growth cone, the
highest levels of DVL-1 were found in the central domain
that contains numerous MTs (Fig. 3, D–F). In the axon
shaft, DVL-1 immunoreactivity seems to localize to re-
gions of the axon where MTs are present (Fig. 3 A). To vi-
sualize MTs, we used acetylated tubulin antibody that la-
bels stable MTs (Bulinski et al., 1988). Double labeling
for acetylated MTs and DVL-1 reveals that high levels of
DVL-1 appear to colocalize with axonal MTs (Fig. 3, G–L).
To test whether DVL-1 interacts with MTs, cerebellar
granule cells were detergent-extracted during fixation, a
procedure that leaves the cytoskeleton and its associated
proteins intact yet removes cytoplasmic and membrane-
associated proteins. DVL-1 immunoreactivity was re-
tained after detergent extraction, although at a lower
level, suggesting that a fraction of DVL-1 is associated
with the cytoskeleton (Fig. 3, J–L). In contrast, the mem-
brane-bound protein, GAP-43, was removed by this treat-
ment (data not shown). Most of the DVL-1 immunoreac-
tivity colocalizes with acetylated MTs (Fig. 3, J–L).
However, at the growth cone, low levels of DVL-1 were
found in areas lacking acetylated MTs, suggesting that
DVL-1 may also be associated with other cytoskeleton
components (Fig. 3, J–L). These results suggest that a
pool of DVL-1 colocalizes with axonal MTs.
To investigate the possible association of DVL-1 with
axonal MTs, we examined whether endogenous DVL-1
cosediments with taxol-polymerized MTs from mice
brain. Indeed, DVL-1 was found in taxol-stabilized MT
fractions (Fig. 4, A and B). In adult brain lysate, similar
levels of the 83-kD isoform were found in the soluble and
pellet fractions when taxol was absent (Fig. 4 A). Addi-
tion of taxol leads to MT polymerization and sedimen-
tation of most of the 83-kD protein into the pellet MT
fraction (Fig. 4 A). We also examined the distribution of
endogenous DVL-1 at early postnatal stages when all
three isoforms of DVL-1 are present. The soluble fraction
from P5 brain contains low levels of the 96-kD DVL-1
protein. However, MT fractions contain the 88-kD pro-
Figure 2. DVL-1 isoforms are developmentally regulated. West-
ern blot analysis of cerebellar extracts from P0, P6, P14, P21, and
adult mice reveals changes in the level of three DVL-1 isoforms.
DVL-1 antibody recognizes three DVL-1 species of 96 kD (ar-
row), 88 kD (arrowhead), and 83 kD (asterisk). At birth, the
three forms of DVL-1 are present, but the 83-kD isoform is ex-
pressed at low levels. During cerebellar maturation, expression
of the 83-kD isoform increases, while the two higher molecular
weight isoforms decrease. Cerebella samples from Dvl-1 null mu-
tant mice, used as a negative control, reveal the absence of the
three DVL-1 isoforms. Expression of DVL-1 in QT-6 cells re-
veals the presence of the high molecular weight isoforms (DVL-1).
The same blot was reprobed with an antibody against extracellu-
lar signal-regulated kinase to control for loading.
Figure 3. The subcellular distribution of DVL-1 in maturing cer-
ebellar granule cell neurons. Granule cell cultures were grown
for 2 d and stained with antibodies to DVL-1 (A, D, G, and J),
GAP-43 (B and E), and acetylated tubulin (H and K). DVL-1 has
a punctate distribution in the neuronal cell bodies and along the
axon shaft (A–C). High levels of DVL-1 were detected in the
central domain of the growth cone (D and F). DVL-1 immu-
nostaining colocalizes with acetylated tubulin along the axon shaft
(G–I). In neurons fixed in the presence of detergent, a pool of
DVL-1 remains colocalized with acetylated tubulin (J–L). CB,
cell body; AS, axon shaft; GC, growth cone. Bar: A–C and G–I,
20 mM; D–F and J–L, 10 mM. 
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tein and low levels of the 96- and 83-kD DVL-1 proteins
(Fig. 4 B). These results show that a higher proportion of
DVL-1 becomes associated with MTs in adult brain com-
pared with younger brain (compare Fig. 4, A and B).
To test further the association of DVL-1 with MTs, we
performed MT depolymerization and repolymerization
experiments in which MTs are depolymerized by cold tem-
perature and repolymerized by GTP at 37
 
8
 
C. After poly-
merization of MTs from adult brain lysate, the 96-kD iso-
form and, more abundantly, the 83-kD DVL-1 isoform
cosediment with polymerized MTs (Fig. 4 C). However,
the 83-kD DVL-1 protein was also found in the soluble
fraction (S1). Interestingly, when the MT pellet (P1) was
subjected to another round of depolymerization, high lev-
els of the DVL-1 immunoreactivity were found in the cold
stable MT pellet. Cold stability is a property of neuronal
MTs that have a high proportion of stable MTs (Webb and
 
Wilson, 1980). These findings suggest that DVL-1 is tightly
associated with the more stable pool of MTs (Fig. 4 C). In
further cycles, no DVL-1 was detected (Fig. 4 C). In con-
trast, the MT-associated protein, MAP-1B, cosediments
with MTs after a few cycles of depolymerization/repoly-
merization (Fig. 4 C), although at much lower levels in the
second and third cycles (Fig. 4 C). The lack of detection of
DVL-1 in further cycles could be due to the low levels of
endogenous DVL-1 in brain samples as compared with
MAP-1B. To test this possibility, we added exogenous
DVL-1 protein to the crude MT fraction. We found that
addition of a lysate from DVL-HA–expressing COS cells
increases the level of DVL-1 in the cold stable pellet; how-
ever, no DVL-1 was detected in the second cycle of poly-
merization (data not shown). Taken together, these exper-
iments show that endogenous DVL-1 protein, especially
the 83-kD isoform, is associated with taxol-stabilized MT
fractions and with cold-stable MTs from the adult brain.
 
DVL-1 Stabilizes Microtubules
 
The interaction of endogenous DVL-1 with neuronal MTs
suggests its possible role in controlling MT organization or,
alternatively, that MTs are just used to transport DVL-1
along the axon. We obtained evidence in favor of the
former possibility when we examined the effect of expres-
sion of 
 
Dvl-HA 
 
on MTs in COS cells. Consistent with pre-
Figure 4. DVL-1 cosediments with stabilized microtubules. (A)
In adult brain lysate, the endogenous 83-kD DVL-1 isoform is
equally distributed between supernatant (S) and pellet (P) frac-
tions (AD). In the presence of taxol, the 83-kD isoform (asterisk)
becomes more abundant in the stabilized MT pellet (P) with low
levels of the 96-kD isoform (arrow; AD1tax). The high molecu-
lar weight band in the soluble fraction of taxol-treated lysate is
not specific. Reprobing for a-tubulin reveals an enrichment of
MTs in the pellet fraction from taxol-containing samples. (B) In
P5 brain samples treated with taxol, high levels of the 88-kD
DVL-1 protein (arrowhead) and low levels of the 96-kD (arrow)
and 83-kD (asterisk) DVL-1 proteins are detected in the taxol-
MT pellet (P). Low levels of the 96-kD isoform is found in the
soluble fraction (S). Reprobing for a-tubulin reveals an enrich-
ment of MTs in the pellet fraction of taxol-treated lysates. (C)
DVL-1 cosediments with the cold stable MT pellet from adult
brain. High levels of the 83-kD (asterisk) and low levels of the 96-
kD (arrow) DVL-1 proteins were found in the soluble (S1) and
MT fractions (P1). After a round of depolymerization, DVL-1 is
most abundant in the cold-stable MT pellet (CSP1). No DVL-1
was detected with MT fractions in subsequent cycles of polymer-
ization. High levels of MAP-1B cosediment with the cold-stable
MT pellet (CSP1), whereas low levels of MAP-1 are found after
MT cycling (P2 and P3).
Figure 5. DVL-1 prevents the loss of stable microtubules in no-
codazole treated COS-7 cells. COS-7 expressing DVL-HA (A–C
and G–I) or GFP (D–F) were examined for the level of MTs (B,
E, and H). COS-7 cells expressing DVL-HA (A) have a normal
level of acetylated MTs (B and C). COS-7 cells expressing GFP
(D–F) or DVL-HA (G–I) were treated with nocodazole to depo-
lymerize MTs. GFP-expressing cells have no acetylated MTs,
similar to neighboring untransfected cells (D–F). Expression of
DVL-HA prevents MT depolymerization by nocodazole (G–I).
Arrows denote MTs resistant to nocodazole in the cell expressing
DVL-HA. *Neighboring untransfected cell, which has lost stable
MTs. (Inset) Small vesicle-like structures are present on some
MTs. Bar, 50 mM. 
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vious studies, DVL-HA forms vesicle-like structures in
transfected cells (Fig. 5, A and G; Fagotto et al., 1999;
Smalley et al., 1999). Cells expressing DVL-1 have similar
levels of acetylated MTs than neighboring nonexpressing
cells (Fig. 5, A–C). Similar results were obtained with
DVL-1 without the epitope tag HA (data not shown). We
then examined the effect of DVL-1 on MTs in cells that
have been treated with 10 
 
m
 
M nocodazole, an MT depoly-
merizing drug (Hoebeke et al., 1976; Lee, 1990). Expres-
sion of GFP (control) does not prevent nocodazole-induced
MT depolymerization as GFP-expressing cells, like un-
transfected cells, have no stable MTs (Fig. 5, D–F). How-
ever, cells expressing DVL-HA have a significant number
of stable MTs after nocodazole treatment (Fig. 5, G–I). We
often observed that DVL-1 induces the formation of pro-
cesses (Fig. 5, G–I). Interestingly, most of the DVL-HA
that colocalizes with MTs is in small vesicle-like structures
(Fig. 5 I, insert). The stabilizing effect of DVL-1 was quan-
tified by counting the number of transfected cells displaying
stable MTs after nocodazole treatment. While expression
of GFP does not stabilize microtubules, DVL-HA driven
by the cytomegalovirus promoter stabilizes MTs in 74.7%
of transfected cells after nocodazole treatment (Fig. 6 C).
These results show that DVL-1 can protect MTs from no-
codazole and can therefore act as an MT stabilizer.
 
The PDZ Domain of DVL-1 Is Required for 
Microtubule Stabilization
 
Dishevelled proteins have three conserved domains that
are required for signaling through distinct pathways
Figure 6. Microtubule stabiliza-
tion by DVL-1 requires the
PDZ domain. (A) Schematic
representation of DVL-1 full-
length and deletion constructs
with the conserved domains. (B)
Western analysis using the anti–
HA antibody shows that COS-7
cells transfected with the full
length and deletion constructs
express similar levels of DVL-1
proteins. (C) Quantification of
the number of transfected cells
containing MTs after nocoda-
zole treatment. The error bars
show mean 6 SEM (results of at
least three experiments). More
than 150 cells were counted in
each experiment for each dele-
tion construct. (D) COS-7 cells
expressing different deletions of
DVL-1 were double-immuno-
stained for DVL-HA (green)
and acetylated tubulin (red).
Cells expressing DDIX have
some MTs after nocodazole
treatment, whereas expression
of  DPDZ confers no protection.
Cells expressing DDEP have
similar levels of MTs as cells ex-
pressing full length DVL-1. Ar-
rows indicate the presence of
very few MTs in DPDZ-express-
ing cells. Bar, 50 mM. 
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(Boutros and Mlodzik, 1999). To begin to define the do-
main(s) of Dishevelled necessary for MT stabilization, we
generated three deletion constructs carrying the HA
epitope tag at the COOH termini (Fig. 6 A). All constructs
express similar levels of proteins after transfection in COS
cells as detected by the HA antibody (Fig. 6 B). Analysis
of nocodazole-treated COS cells shows that 74.7% of the
cells expressing the full-length DVL-1 have stable MTs
(Fig. 6 C). Deletion of the DIX domain, (
 
D
 
DIX-DVL-1)
confers stabilization to 34% of cells (Fig. 6, C and D) with
similar numbers of MTs, as compared with full-length
DVL-1 (Figs. 5 I and 6 D). Expression of 
 
D
 
PDZ-DVL-1
results in the presence of very few stable MTs in only 23%
of the transfected cells. In contrast, deletion of the COOH
end, containing the DEP domain, does not affect the abil-
ity of DVL-1 to stabilize MTs, as 57.5% of the cells con-
tain high numbers of stable MTs (Fig. 6, C and D). These
experiments show that the DEP domain of DVL-1 is not
required for MT stabilization, while the PDZ domain and,
to a lesser extent, the DIX domain are required for MT
stabilization.
 
The Microtubule Stabilizing Activity of DVL-1 Is 
Mediated through GSK-3
 
b
In the WNT signaling pathway, activation of Dishevelled
results in the inhibition of GSK-3b (Cadigan and Nusse,
1997; Arias et al., 1999). GSK-3b itself phosphorylates a
number of MT-associated proteins such as Tau, MAP-1B,
and MAP-2 that control MT stability (Hanger et al., 1992;
Mandelkow et al., 1992; Lucas et al., 1998). Therefore,
DVL-1 might regulate MT stability through inhibition of
GSK-3b. Consistent with this idea, expression of GSK-3b
blocks the ability of DVL-1 to protect MTs against nocoda-
zole (Fig. 7, A–C). This effect of GSK-3b depends on its ki-
nase activity as a kinase-dead, dominant-negative form of
GSK-3b (dnGSK-3b) fails to block the MT stabilizing ef-
fect of DVL-1 (Fig. 7, D–F and J). Neither GSK-3b-HA
nor dnGSK-3bHA when expressed alone have a detectable
effect on MT stability in nocodazole-treated cells (data not
shown). Expression of DVL-1 under the SV40 promoter
prevents MT depolymerization in 65.6% of transfected
cells (Fig. 7 J), whereas 15.2% of cells expressing DVL-1
and GSK-3b-HA display stable MTs after nocodazole
treatment (Fig. 7 J). dnGSK-3b, when coexpressed with
DVL-1, protects MTs against depolymerization by nocoda-
zole in 74.4% of cells (Fig. 7 J). Interestingly, coexpression
of dnGSK-3b and DVL-1 increases the number of cells that
retain their MTs (Fig. 7 J), suggesting that dnGSK-3b en-
hances DVL-1 function. These results suggest that DVL-1
stabilizes MTs through the inhibition of GSK-3b. To test
further this idea, we examined the effect of lithium, a direct
inhibitor of GSK-3b and an activator of the WNT pathway
(Klein and Melton, 1996). Control NaCl has no effect on
MT stability (Fig. 7 G). In contrast, lithium chloride stabi-
lizes MTs in COS cells treated with nocodazole (Fig. 7, H
and I). Lithium has a concentration-dependent MT stabiliz-
ing effect. At 20 mM lithium, few MTs are stabilized (Fig. 7
H), whereas more MTs are stabilized in the presence of 40
mM lithium (Fig. 7 I). The addition of myo-inositol to lith-
ium-treated cells did not affect the MT stabilizing effect of
lithium, suggesting that depletion of inositol, another
known effect of lithium (Atack et al., 1995), is not involved
in this process (data not shown). These results suggest that
the MT stabilizing activity of DVL-1 is mediated by the in-
hibition of GSK-3b.
DVL-1 Stabilizes Axonal Microtubules
DVL-1 colocalizes with axonal MTs in maturing neurons
(Fig. 3). To test whether DVL-1 also regulates the stability
of axonal MTs, we examined the effect of expression of
DVL-HA in differentiated NB2a neuroblastoma cells. Un-
transfected and GFP-expressing NB2a cells have bundles
of acetylated MTs along the axon (Fig. 8, B and C, and data
Figure 7. Inhibition of GSK-3b by DVL-1 or lithium stabilizes
microtubules. (A–C) COS-7 cells double transfected with DVL-1
and GSK-3b-HA were treated with nocodazole. The cells were
fixed and triple-stained with antibodies to DVL-1 (green), HA
(blue), and acetylated tubulin (red). Cells expressing DVL-1 and
GSK-3b-HA have very low level of acetylated MTs (asterisk),
whereas a neighboring cell expressing only DVL-1 (C, arrow)
contains MTs after nocodazole treatment. (D–F) Expression
of the kinase-dead form of GSK-3b (dnGSK-3b-HA) in DVL-
1–expressing cells does not block the ability of DVL-1 to protect
MTs against nocodazole treatment. (G) COS-7 cells cultured in
control NaCl-containing medium have no stable MTs after no-
codazole treatment. (H) Cells treated with 20 mM LiCl have few
acetylated MTs after nocodazole treatment, whereas in the pres-
ence of 40 mM LiCl (I), a larger proportion of acetylated MTs is
present in nocodazole-treated cells. (J) Graph shows the percent-
age of cells containing MTs after nocodazole treatment. Note
that expression of dnGSK-3b and DVL-1 results in a small but
significant increase in the number of cells containing MTs (65.6%
and 74.4%; t test, P , 0.005). Values are mean 6 SEM from
three separate experiments. Bar, 50 mM.The Journal of Cell Biology, Volume 151, 2000 90
not shown). In contrast, expression of DVL-HA increases
the level of acetylated MTs in NB2a neurons (Fig. 8, A–C).
Treatment with nocodazole results in the loss of acetylated
MTs and retraction of axons in untransfected NB2a cells
(Fig. 8, E and F), whereas DVL-HA protects stable MTs
from nocodazole treatment (Fig. 8, D–F), as observed in
COS cells (Fig. 5, G–I). DVL-HA–expressing cells do not
retract their axons in the presence of nocodazole (Fig. 8,
D–F). Thus, DVL-1 increases the level of acetylated MTs
and stabilizes axonal MTs against the depolymerizing effect
of nocodazole. Like in COS cells, lithium treatment also re-
sults in increased MT stability (data not shown). These
findings suggest that neuronal DVL-1 regulates, through
GSK-3b, MT stability in developing axons.
Discussion
In this paper, we demonstrate a novel function of DVL-1
in regulating MT stability. In neurons, endogenous DVL-1
colocalizes with axonal MTs and sediments with MT frac-
tions. Our studies show that DVL-1 stabilizes MTs, a pro-
cess mediated by the inhibition of GSK-3b. These findings
suggest a possible mechanism by which Dishevelled pro-
teins could regulate cell morphology, cell polarity, and
asymmetric cell divisions.
Dishevelled Is Associated with Microtubules
Previous studies in Xenopus embryos have shown that
Dsh-GFP moves along MTs, suggesting that Dishevelled
interacts with MTs, although biochemical evidence was
not provided (Miller et al., 1999). Here we demonstrate a
physical association of endogenous DVL-1 with MTs iso-
lated from brain tissues. Consistent with these findings,
DVL-1 is mainly localized to neurons that contain high
levels of stable MTs. Thus, Dishevelled proteins associate
with MTs in different cell types, suggesting a general role
for Dishevelled in regulating MT organization.
Three isoforms of DVL-1 are expressed during postna-
tal cerebellar development with the 83-kD DVL-1 isoform
becoming more predominant in adult cerebellum. This iso-
form is tightly associated with cold stable MT fractions,
representing axonal MTs (Webb and Wilson, 1980; Brady
et al., 1984). In agreement with this finding, immunofluo-
rescence studies show that DVL-1 colocalizes with MTs in
developing axons. The association with cold stable MTs
has been observed with STOP proteins and Doublecortin,
both microtubule-associated proteins that regulate MT
stability (Guillaud et al., 1998; Francis et al., 1999; Gleeson
et al., 1999). DVL-1 cosediments with taxol or GTP-poly-
merized MTs. When brain MTs are run through cycles of
depolymerization and repolymerization, most of the en-
dogenous DVL-1 sediments with the first MT pellet and
with the cold stable pellet. However, no DVL-1 was de-
tected in further rounds of depolymerization and repoly-
merization even when exogenous DVL-1 protein was
added. The presence of DVL-1 in the pellet after microtu-
bule depolymerization suggests that a pool of DVL-1 is as-
sociated with cytoskeleton components, other than micro-
tubules. Interestingly, recent studies show that DVL-1
colocalizes with actin fibers (Torres and Nelson, 2000). Al-
ternatively, the presence of DVL-1 in the cold stable pellet
may indicate a very strong association with a pool of mi-
crotubules. Microtubule-associated proteins that regulate
MT stability cycle with MTs to different degrees. MAP-2
and Tau cycle well, while MAP-1B has a relatively poor
cycling ability (Gordon-Weeks et al., 1995). Thus, the lack
of cycling of DVL-1 should not be interpreted as a poor
association with MTs. On the contrary, the presence of
high levels of DVL-1 in the cold stable pellet, which repre-
sents the most stable pool of MTs, suggests that DVL-1 is
tightly associated with stable MTs.
How is DVL-1 associated with MTs? DVL-1 does not
have a distinguishable MT-binding domain like other MT
binding proteins (Drewes et al., 1998). Therefore, DVL-1
could bind to MTs through a novel, as yet unidentified,
MT binding domain. Alternatively, DVL-1 may associate
indirectly with MTs by interacting with other microtubule-
binding proteins. Interestingly, Adenomatous polyposis
coli (APC), a protein that regulates WNT signaling, has a
MT binding domain (Munemitsu et al., 1994; Papkoff et
al., 1996; McCartney et al., 1999). APC has recently been
shown to form a complex with Axin, a protein that inter-
acts with Dishevelled (Fagotto et al., 1999; Smalley et al.,
1999). As APC increases MT assembly (Munemitsu et al.,
1994), DVL-1 could regulate MT dynamics by interacting
with proteins such as APC. Further studies are needed to
address this possibility.
DVL-1 Stabilizes Microtubules through
GSK-3b Inhibition
DVL-1 regulates MT stability as expression of DVL-1 in-
creases the level of acetylated MTs and protects MTs from
depolymerization by nocodazole in COS and neuroblas-
toma 2a cells. Similar results have been observed with mi-
crotubule-associated proteins such as Tau, MAP-1B, and
MAP-2, which increase MT stability (Baas et al., 1994;
Takemura et al., 1992). Thus, DVL-1 acts as a MT stabiliz-
ing factor.
How does DVL-1 regulate MT stability? Dishevelled
proteins contain three conserved domains, a DIX domain
also present in Axin, a negative regulator of the WNT sig-
naling pathway, a PDZ domain present in a number of
junctional proteins of the PSD-95 and Disc-large family,
Figure 8. DVL-1 stabilizes axonal microtubules. (A–C) Differen-
tiated NB2a cells expressing DVL-HA have higher levels of
acetylated MTs (arrows) than untransfected neighboring cells (ar-
rowhead). (D–F) Neurons expressing DVL-HA have acetylated
MTs after nocodazole treatment (arrow), whereas untransfected
cells have no acetylated MTs (asterisk). Bar, 25 mM.Krylova et al. Mouse Dishevelled Protein, DVL-1, Regulates Microtubule Stability 91
and a DEP domain present in the Caenorhabditis elegans
protein Egl-10 and in Plecktrin (for review, see Boutros
and Mlodzik, 1999). The PDZ domain is required for Ar-
madillo stabilization through the canonical WNT pathway
(Sokol et al., 1995; Yanagawa et al., 1995). In contrast, the
DEP domain, but not the PDZ domain, is required for
JNK signaling (Boutros et al., 1998; Li et al., 1999). Here,
we show that the PDZ domain is required for MT stabiliza-
tion, while deletion of the DIX domain has a weaker ef-
fect. In contrast, deletion of the DEP domain does not
affect the MT stabilizing function of DVL-1. The require-
ment of the PDZ domain suggests that DVL-1 may be act-
ing through the canonical pathway. Consistent with these
findings, DVL-1 stabilizes MTs through the inhibition of
GSK-3b, a downstream component of the canonical WNT
pathway. This mechanism is supported by three findings.
Firstly, expression of GSK-3b blocks the MT stabilizing ac-
tivity of DVL-1. Secondly, dnGSK-3b enhances DVL-1
function. Thirdly, lithium, an inhibitor of GSK-3b (Klein
and Melton, 1996), mimics the MT stabilizing activity of
DVL-1. Inhibition of GSK-3b by DVL-1 could lead to
changes in the phosphorylation of microtubule-associated
proteins such as Tau, MAP-1B, and MAP-2 that are direct
targets of GSK-3b (Hanger et al., 1992; Lucas et al., 1998;
Sanchez Martin et al., 1998). Studies of Tau and MAP-1B
show that GSK-3b–mediated phosphorylation decreases
the ability of Tau to bind to MTs and decreases MT stabili-
zation by MAP-1B (Wagner et al., 1996; Hong et al., 1997;
Goold et al., 1999). Thus, inhibition of GSK-3b by DVL-1
may change the ability of MAPs to stabilize MTs. Al-
though inhibition of GSK-3b by lithium stabilizes MTs,
DVL-1 has a stronger stabilizing effect than high levels of
lithium. Thus, it is likely that DVL-1 promotes MT stabil-
ity via inhibition of GSK-3b, but an alternative pathway
may also contribute to this function of DVL-1. Dishevelled
has recently been found to colocalize with actin fibers
(Torres and Nelson, 2000). More importantly, Dishevelled
has been proposed to influence the actin cytoskeleton
through the JNK pathway (Strutt et al., 1997; Axelrod et
al., 1998). As MT dynamics is influenced by actin, Dishev-
elled could regulate MTs indirectly through the JNK path-
way by changing the actin cytoskeleton. However, this
mechanism seems unlikely, as the DEP domain of DVL-1,
essential for the JNK pathway, is not required for MT sta-
bility. Consequently, our data suggest that MT stabiliza-
tion by DVL-1 is mediated through GSK-3b signaling and
a parallel, as yet unidentified, pathway.
In maturing neurons, endogenous DVL-1 colocalizes
with axonal MTs that contain high levels of stable MTs.
More importantly, DVL-1 increases the level of stable
MTs in differentiated NB2a neuroblastoma cells and pro-
tects axonal MTs against nocodazole treatment. These
findings suggest that neuronal DVL-1 may stabilize axonal
MTs in vivo. Consistent with this view, a higher proportion
of endogenous DVL-1 becomes associated with MTs from
adult brain samples, which are enriched in stable MTs.
Moreover, DVL-1 sediments with cold stable MT fractions
representing the most stable pool of MTs. Thus, the local-
ization of DVL-1 to MTs correlates with increased MT
stability in maturing axons. Further studies are needed to
address the in vivo role of DVL-1 in microtubule dynamics
in developing neurons.
Dishevelled in Cell Polarity and Movement
Dishevelled has been implicated in three processes in
which the reorganization of the cytoskeleton is essential:
planar polarity, cell movement, and mitotic spindle orien-
tation. In Drosophila, the epithelial planar polarity mutant
phenotype is characterized by the random orientation of
cells within the epithelia in the wing, leg, and eye. In the
wing, epithelial cells are oriented along the proximal-distal
axis and each develops a hair pointing towards the distal
end. Mutations in dishevelled or frizzled result in the ran-
dom orientation of this hair (Adler, 1992). In the Dro-
sophila eye, Fz/Dsh signaling affects mirror-symmetric ar-
rangement of ommatidia (Cooper and Bray, 1999; Fanto
and Mlodzik, 1999). Dishevelled lies upstream of RhoA/
Rac and the JNK kinase pathway in the control of planar
polarity in the eye and wing (Strutt et al., 1997; Boutros et
al., 1998). In addition, mutational analyses have demon-
strated that Armadillo/b-catenin or pangolin/T-cell factor
are not required for planar polarity in the eye (Boutros et
al., 1998). However, the role of shaggy, the Drosophila ho-
mologue of GSK-3, is less clear. Although shaggy mutants
do not exhibit a planar polarity phenotype in the wing
(Axelrod et al., 1998), overexpression studies showed that
shaggy produces a similar but weaker planar polarity phe-
notype in the eye to those observed in fz or dsh (Tomlin-
son et al., 1997). Therefore, it is possible that Dishevelled
functions through shaggy/GSK-3 in planar polarity de-
pending on the cellular context.
Recent studies in Xenopus and zebrafish embryos have
shown that wnt-11 regulates convergent extension move-
ments through Dishevelled (Heisenberg et al., 2000; Tada
and Smith, 2000; Wallingford et al., 2000). Dishevelled
does not signal through the canonical pathway, as b-cate-
nin or Tcf-3 are not required (Tada and Smith., 2000). Al-
though the role of GSK-3 has not been tested in this
process, the requirement of the DEP domain, but not
the PDZ domain, suggests that Dishevelled is signaling
through a similar pathway to that involved in Drosophila
planar polarity.
Dishevelled also regulates the orientation of the mitotic
spindle. Mutations in the Drosophila dishevelled and friz-
zled result in random orientation of the mitotic spindle in
the asymmetric cell divisions during the development of
mechanosensory organs (Gho and Schweisguth, 1998). In
C. elegans, components of the Wnt pathway upstream and
downstream of dishevelled regulate the orientation of the
mitotic spindle during asymmetric cell divisions. gsk-3,
mom-5/fz, and mom-1/porc regulate the orientation of the
mitotic spindle (Schlesinger et al., 1999). Although the
role of dishevelled has not been demonstrated in this sys-
tem, these findings strongly suggest that WNT/FZ signal-
ing through GSK-3 regulates the organization and/or ori-
entation of MT structures. The mechanism by which the
cytoskeleton is reorganized by WNT/FZ–mediated signal-
ing remains elusive.
In the present work, we demonstrate that endogenous
DVL-1 associates with axonal MTs that contain a large
pool of stable MTs. DVL-1 also stabilizes MTs in dividing
cells and differentiated neurons. Our data is consistent
with the idea that activation of Dishevelled, depending on
the cellular context, results in MT stabilization through theThe Journal of Cell Biology, Volume 151, 2000 92
inhibition of GSK-3b. The localization of Dishevelled to
MTs may target its function within the cell. Local inhibi-
tion of GSK-3b by DVL-1 may result in local changes in
the phosphorylation of GSK-3b targets that regulate MT
dynamics. This novel MT stabilizing function of DVL-1
provides a possible mechanism for regulating cell polarity.
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